PlainRecalls
FDA Drug Moderate Class II Ongoing

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)

Reported: April 16, 2025 Initiated: March 21, 2025 #D-0354-2025

Product Description

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Details

Units Affected
506,080 vials
Distribution
U.S. Nationwide
Location
Bengaluru, N/A

Frequently Asked Questions

What product was recalled?
Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton). Recalled by Somerset Therapeutics Private Limited. Units affected: 506,080 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Media fill with bacterial contamination
Which agency issued this recall?
This recall was issued by the FDA Drug on April 16, 2025. Severity: Moderate. Recall number: D-0354-2025.